88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Over 40 Studies Featuring Akeso's Innovative Oncology Agents to Be Presented at ASCO 2026: Ivonescimab's HARMONi-6 Overall Survival Data Selected for Plenary Session HONG KONG , May 26, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") a nnounced that more than 40 clinical studies of its oncology portfolio will be presented ... 2026-05-26T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
WuXi Vaccines' Drug Substance Facility Receives Brazil ANVISA GMP Certification for Dengue Vaccine Manufacturing SUZHOU, China , May 26, 2026 /PRNewswire/ -- WuXi Vaccines, a wholly-owned subsidiary of WuXi Biologics, dedicated to vaccine Contract Development and Manufacturing Organization (CDMO), announced today ... 2026-05-26T Biotechnology Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
sweelin® Approved in Singapore as a Food Additive expanding Amai Proteins' Regulatory Footprint into Asia Amai Proteins has achieved a major regulatory milestone with the Singapore Food Agency (SFA) approval of sweelin®, its flagship sweet protein, for use as a sweetening agent in food and beverage pr ... 2026-05-25T Beverages Biotechnology Food/Beverages Health Care/Hospital
Meet Clicklinks: The Innovation Hub for Original Drug Discovery SHANGHAI , May 23, 2026 /PRNewswire/ -- For many participants in the innovative drug discovery arena, AI-STAL and SAI-DA are already familiar names within the Sanyou Bio ecosystem. AI-STAL is recognized ... 2026-05-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Gene Solutions Showcases AI-Powered Multi-Omics Liquid Biopsy Innovations at TJCC 2026: Advancing Precision Oncology in Taiwan Satellite symposium and exhibition engagement highlighted strong physician interest in MRD, MCED, and evidence-driven adoption of genomic testing . ... 2026-05-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals Trade show news
Mabwell Announces Latest Clinical Data on 9MW2821 to Be Presented at 2026 ASCO Annual Meeting as Oral and Poster Presentations SHANGHAI , May 22, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, will present multiple clinical study results ... 2026-05-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nuance Pharma Announces IND Clearance for Actair® Pivotal Clinical Trial in China NMPA Approval Marks Key Milestone in Advancing House Dust Mite Allergy Immunotherapy to Chinese Patients ... 2026-05-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting TAIPEI , May 22, 2026 /PRNewswire/ -- Formosa Pharmaceuticals, Inc. announces that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310 , a novel bispecific ... 2026-05-22T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Lunit Highlights AI-Powered IHC and Tumor Microenvironment Research at ASCO 2026 At ASCO 2026, Lunit will present precision patient stratification and biomarker-driven oncology research through AI-powered HER2/IHC biomarker quantification and spatial tumor microenvironment an ... 2026-05-22T Biotechnology Health Care/Hospital Trade show news
Kelun-Biotech Announces Phase III Trial of Sacituzumab Tirumotecan (sac-TMT) versus Chemotherapy as First‑line Treatment for Advanced TNBC Met Primary Endpoint of PFS CHENGDU, China , May 21, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced today that the Independent Data ... 2026-05-21T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved